Market Place
Sourcing Support
Tetra Bio-Pharma reports results from trial of ARDS-003 and Favipiravir
07 Dec 2022 //
CLINICALTRIALSARENA
Appili Therapeutics Provides Update Ph3 PRESECO Clinical Trial Evaluating Avigan
14 Oct 2022 //
APPILITHERAPEUTICS
Japan`s Fujifilm stops work on Avigan as COVID drug
14 Oct 2022 //
HEALTH ET
Fujifilm terminates P III enrollment for Avigan drug trial in Japan
15 Mar 2022 //
BIOSPECTRUMASIA
Egis Favipiravir Drug Licenced for Covid-19 Treatment
20 Dec 2021 //
HUNGARYTODAY
Dr. Reddy’s API team is a 2021 winner
11 Nov 2021 //
PRESS RELEASE
Dr. Reddy’s API team is a 2021 winner in – API Supplier year at Global generics
11 Nov 2021 //
PRESS RELEASE
UK COVID-19 patients able to take GP prescribed medicine at home
26 Oct 2021 //
PHARMATIMES
Ex-FDA officials ask SCOTUS to take up J&J talc case; and more
05 Oct 2021 //
ENDPTS
AiPharma and Appili Therapeutics form strategic alliance
05 Oct 2021 //
PHARMAFIELD
Appili and AiPharma Announce Strategic Alliance and Equity Transaction
29 Sep 2021 //
BUSINESSWIRE
Appili Signs Agreement with FUJIFILM; Funds Support for Clinical Trial Program
20 Sep 2021 //
BUSINESSWIRE
Appili Therapeutics Announces Completion of Patient Enrollment for Avigan®
17 Sep 2021 //
BUSINESSWIRE
Glenmark concludes study on COVID drug Favipiravir
14 Sep 2021 //
ECONOMICTIMES
FDC launches favipiravir oral suspension to treat Covid-19
13 Jul 2021 //
PHARMABIZ
FDC launches favipiravir oral suspension to treat Covid-19
13 Jul 2021 //
PHARMABIZ
FDC launches Favipiravir oral suspension to treat COVID-19 in India
12 Jul 2021 //
ECONOMIC TIMES
FDC launches Favipiravir oral suspension to treat COVID-19 in India
12 Jul 2021 //
ECONOMIC TIMES
FDC launches favipiravir oral suspension to treat Covid-19
12 Jul 2021 //
PHARMABIZ
New Fujifilm CEO focuses on drug ingredients unit after Avigan stumbles
10 Jul 2021 //
REUTERS
Gujarat FDCA makes crackdown on illegal sale spurious COVID-19 drug
22 Jun 2021 //
PHARMABIZ
Announcement of Environmental Impact Zhejiang Hengkang favipiravir production
07 Apr 2021 //
PRESS RELEASE
Viriom, Chromis’ Avifavir reduces time to virus elimination in Covid-19 patients
09 Mar 2021 //
PHARMACEUTICAL-TECHNOLOGY
COVID-19 therapeutics tracker
26 Feb 2021 //
RAPS
Fujifilm to restart clinical trial of Avigan to treat COVID-19: media
22 Feb 2021 //
REUTERS
Fujifilm`s Avigan shows no significant benefit on COVID-19 mortality: study
18 Feb 2021 //
REUTERS
Fujifilm`s Avigan shows no significant benefit on COVID-19 mortality: study
18 Feb 2021 //
REUTERS
Appili Provides Enrollment Update for Its Phase 3 PRESECO Trial Evaluating
28 Jan 2021 //
BIOSPACE
Dr. Reddy’s seeks approval from Health Canada for Covid-19 treatment
23 Dec 2020 //
PHARMACEUTICAL-TECHNOLOGY
Dr. Reddy’s seeks approval from Health Canada for Covid-19 treatment
23 Dec 2020 //
RUTERS
Dr. Reddy`s , Global Response Aid, and Appili Announce the Filing REEQONUS™
22 Dec 2020 //
BUSINESSWIRE
Avigan effectiveness not yet clear, Japan health ministry panel says
22 Dec 2020 //
JAPANTIMES
Dr. Reddy`s, Global Response Aid, & Appili the Filing for REEQONUS™
22 Dec 2020 //
BUSINESSWIRE
Avigan effectiveness not yet clear, Japan health ministry panel says
22 Dec 2020 //
JAPANTIMES
Appili Therapeutics initiates dosing in Covid-19 drug trial in US
03 Dec 2020 //
CLINICALTRIALSARENA
Health Canada Clears Appili Therapeutics for New Ph3 Trial
24 Nov 2020 //
BUSINESSWIRE
Health Canada Clears Appili Therapeutics for New Pha3 Trial to Avigan Tablets
24 Nov 2020 //
BUSINESSWIRE
Recently published data on Favipiravir treatment for mild to moderate COVID-19
23 Nov 2020 //
PRNEWSWIRE
FDC unveils stronger versions of Favipiravir drugs for COVID-19 treatment
30 Oct 2020 //
INDIANINFOLINE
Appili Therapeutics Joins Dr. Reddy’s, Global Response Aid, and FUJIFILM
30 Oct 2020 //
BIOSPACE
Appili Therapeutics Joins Dr. Reddy’s, Global Response Aid, and FUJIFILM
30 Oct 2020 //
BUSINESSWIRE
SC seeks Centre`s reply on plea alleging no approval for Remdesivir, Favipiravir
29 Oct 2020 //
ECONOMICTIMES
First Participants Dosed in Appili ’ Ph2 Clinical Trial Evaluating Favipiravir
20 Oct 2020 //
PRESS RELEASE
Fujifilm seeks approval for Avigan as COVID-19 treatment in Japan
19 Oct 2020 //
REUTERS
Fujifilm Filed an Application for Partial Changes to the MFG & MKT Approval
16 Oct 2020 //
PRESS RELEASE
After tablets, Hetero working on antiviral medicine Favipiravir injections
08 Oct 2020 //
ECONOMICTIMES
Japan denies plan to approve Avigan as COVID-19 treatment in November
06 Oct 2020 //
ARABNEWS
Tagoor Labs gets DCGI approval for Favipiravir production
05 Oct 2020 //
BIOSPECTRUMASIA
Maharashtra FDA assures CDSCO of adequate stock of essential COVID-19 drugs
05 Oct 2020 //
PHARMABIZ
COVID-19 therapeutics tracker
02 Oct 2020 //
RAPS
Fujifilm signs manufacturing contract with U.S. firm VLP for COVID-19 vaccine
02 Oct 2020 //
REUTERS
Indoco launches Fevindo 400 mg tablets for COVID-19
27 Sep 2020 //
PHARMABIZ
Hetero launches pack of generic Covid-19 drug favipiravir at Rs 2,640
25 Sep 2020 //
BUSINESS-STANDARD
Legend CEO probe; AZ-Samsung biologics deal; Fujifilm`s Avigan in COVID-19
25 Sep 2020 //
FIERCE PHARMA
Russia to supply 17 more countries with COVID-19 drug Avifavir
25 Sep 2020 //
REUTERS
Fujifilm`s flu drug Avigan improves COVID-19 recovery time
24 Sep 2020 //
FIERCE PHARMA
Fujifilm`s Avigan shown to be effective in Japanese Phase-3 trial for COVID-19
22 Sep 2020 //
REUTERS
Fujifilm ends delayed Avigan clinical test, looks to gov`t application
21 Sep 2020 //
KYODO NEWS
Japanese Approval Sought For Avigan To Treat COVID-19
20 Sep 2020 //
NIKKEI
Russia approves first COVID-19 prescription drug for sale in pharmacies
18 Sep 2020 //
REUTERS
